ID   ADSV_CHICK              Reviewed;         717 AA.
AC   Q5ZIV9;
DT   08-FEB-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   02-DEC-2020, entry version 88.
DE   RecName: Full=Adseverin;
DE   AltName: Full=Scinderin;
GN   Name=SCIN; ORFNames=RCJMB04_23d8;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=17097081; DOI=10.1016/j.ydbio.2006.09.052;
RA   Nurminsky D., Magee C., Faverman L., Nurminskaya M.;
RT   "Regulation of chondrocyte differentiation by actin-severing protein
RT   adseverin.";
RL   Dev. Biol. 302:427-437(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=CB; TISSUE=Bursa of Fabricius;
RX   PubMed=15642098; DOI=10.1186/gb-2004-6-1-r6;
RA   Caldwell R.B., Kierzek A.M., Arakawa H., Bezzubov Y., Zaim J., Fiedler P.,
RA   Kutter S., Blagodatski A., Kostovska D., Koter M., Plachy J., Carninci P.,
RA   Hayashizaki Y., Buerstedde J.-M.;
RT   "Full-length cDNAs from chicken bursal lymphocytes to facilitate gene
RT   function analysis.";
RL   Genome Biol. 6:R6.1-R6.9(2005).
CC   -!- FUNCTION: Ca(2+)-dependent actin filament-severing protein that has a
CC       regulatory function in exocytosis by affecting the organization of the
CC       microfilament network underneath the plasma membrane. In vitro, also
CC       has barbed end capping and nucleating activities in the presence of
CC       Ca(2+). Severing activity is inhibited by phosphatidylinositol 4,5-bis-
CC       phosphate (PIP2) (By similarity). Required for megakaryocyte
CC       differentiation, maturation, polyploidization and apoptosis with the
CC       release of platelet-like particles (By similarity). Plays a role in
CC       osteoclastogenesis (OCG) and actin cytoskeletal organization in
CC       osteoclasts (By similarity). Regulates chondrocyte proliferation and
CC       differentiation (PubMed:17097081). Inhibits cell proliferation and
CC       tumorigenesis. Signaling is mediated by MAPK, p38 and JNK pathways (By
CC       similarity). {ECO:0000250|UniProtKB:Q28046,
CC       ECO:0000250|UniProtKB:Q60604, ECO:0000250|UniProtKB:Q9Y6U3,
CC       ECO:0000269|PubMed:17097081}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q60604}. Cell projection, podosome
CC       {ECO:0000250|UniProtKB:Q60604}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the pre-hypertrophic and hypertrophic
CC       cartilage of the embryonic growth plate. {ECO:0000269|PubMed:17097081}.
CC   -!- INDUCTION: Up-regulated in pre-hypertrophic and hypertrophic
CC       chondrocytes during the embryonic development of long bones.
CC       {ECO:0000269|PubMed:17097081}.
CC   -!- SIMILARITY: Belongs to the villin/gelsolin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG32334.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAG32334.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ020143; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ720675; CAG32334.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_001231522.1; NM_001244593.1.
DR   SMR; Q5ZIV9; -.
DR   STRING; 9031.ENSGALP00000017495; -.
DR   PaxDb; Q5ZIV9; -.
DR   GeneID; 420588; -.
DR   KEGG; gga:420588; -.
DR   CTD; 85477; -.
DR   eggNOG; KOG0443; Eukaryota.
DR   HOGENOM; CLU_002568_3_2_1; -.
DR   InParanoid; Q5ZIV9; -.
DR   OMA; FKQFFFK; -.
DR   OrthoDB; 1376537at2759; -.
DR   PhylomeDB; Q5ZIV9; -.
DR   PRO; PR:Q5ZIV9; -.
DR   Proteomes; UP000000539; Unplaced.
DR   Bgee; ENSGALG00000010770; Expressed in colon and 12 other tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0002102; C:podosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IBA:GO_Central.
DR   GO; GO:0051014; P:actin filament severing; IBA:GO_Central.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IBA:GO_Central.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IBA:GO_Central.
DR   GO; GO:0030031; P:cell projection assembly; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IDA:UniProtKB.
DR   Gene3D; 3.40.20.10; -; 6.
DR   InterPro; IPR029006; ADF-H/Gelsolin-like_dom_sf.
DR   InterPro; IPR030012; Adseverin.
DR   InterPro; IPR007123; Gelsolin-like_dom.
DR   InterPro; IPR036180; Gelsolin-like_dom_sf.
DR   InterPro; IPR007122; Villin/Gelsolin.
DR   PANTHER; PTHR11977; PTHR11977; 1.
DR   PANTHER; PTHR11977:SF78; PTHR11977:SF78; 1.
DR   Pfam; PF00626; Gelsolin; 6.
DR   PRINTS; PR00597; GELSOLIN.
DR   SMART; SM00262; GEL; 6.
DR   SUPFAM; SSF82754; SSF82754; 1.
PE   2: Evidence at transcript level;
KW   Actin capping; Actin-binding; Calcium; Cell junction; Cell projection;
KW   Cytoplasm; Cytoskeleton; Metal-binding; Reference proteome; Repeat.
FT   CHAIN           1..717
FT                   /note="Adseverin"
FT                   /id="PRO_0000404255"
FT   REPEAT          28..108
FT                   /note="Gelsolin-like 1"
FT   REPEAT          148..220
FT                   /note="Gelsolin-like 2"
FT   REPEAT          265..340
FT                   /note="Gelsolin-like 3"
FT   REPEAT          408..483
FT                   /note="Gelsolin-like 4"
FT   REPEAT          526..590
FT                   /note="Gelsolin-like 5"
FT   REPEAT          628..703
FT                   /note="Gelsolin-like 6"
FT   REGION          1..363
FT                   /note="Actin-severing"
FT                   /evidence="ECO:0000250"
FT   REGION          112..119
FT                   /note="Polyphosphoinositide binding"
FT                   /evidence="ECO:0000250"
FT   REGION          138..146
FT                   /note="Polyphosphoinositide binding"
FT                   /evidence="ECO:0000250"
FT   REGION          364..715
FT                   /note="Ca(2+)-dependent actin binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        235..238
FT                   /note="Poly-Asp"
FT   METAL           538
FT                   /note="Calcium 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   METAL           539
FT                   /note="Calcium 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   METAL           562
FT                   /note="Calcium 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   METAL           643
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   METAL           644
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   METAL           666
FT                   /note="Calcium 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6U3"
FT   CONFLICT        96
FT                   /note="S -> R (in Ref. 1; DQ020143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="E -> K (in Ref. 2; CAG32334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="L -> V (in Ref. 2; CAG32334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        253..254
FT                   /note="MV -> KA (in Ref. 1; DQ020143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        536
FT                   /note="N -> D (in Ref. 1; DQ020143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        686
FT                   /note="D -> V (in Ref. 1; DQ020143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        713
FT                   /note="N -> T (in Ref. 1; DQ020143)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   717 AA;  80533 MW;  1447FE1421E19AE7 CRC64;
     MAPERHPPAF EGAGQESGLQ VWRVERLELV PVPPSRHGDF FVGDAYLVLH TVRRGAAVAY
     RLHYWLGKEC TQDESTAAAI FTVQLDDYLG GKPVQSREIQ GYESNEFVSY FKGGIKYKAG
     GVASGFNHVV TNDLSAQRLL HIKGRRVVRA TEVPLTWASF NKGDCFIIDL GNEIYQWCGS
     SCNKYERLKA TQVAVGIRDN ERNGRSRLIT VEEGSEPDEL ITVLGEKPEL PECSDDDDEM
     ADIANRKSAK LYMVSDASGS MKLSVVAEEN PFSMAMLLSE ECFILDNGAA RKIFVWKGKD
     ANPQERKAAM KNAETFVQQM NYPANTQIQV LPEGGETPIF KQFFKDWKDK DQSDGFGKVY
     VTERVAKIEQ IEFDATKLHE SPQMAAQHNM IDDGSGKVQI WRVESSGRVP VEPETYGQFY
     GGDCYIILYT YPKGQIIYTW QGACATKDEL TASAFLTVQL DRSLNDQAVQ IRVSQGKEPP
     HLLSLFKNKP LIVYKNGTSK KEGQKPAPPT RLFQIRRNLM SVTRIAEVDV DAMSLNSNDA
     FVLKLPNNTG YTWVGKGVNK EEEQGAQYIA SVLKCQTAKI NEGQEPEEFW KALGGKKKYQ
     TSSQLLTKAE DHPPRLFGCS NKTGRFIIEE VPGEFTQDDL AEDDVMLLDA WEQVFVWIGK
     EANETERQES VKSAKRYIET DPSGRDKGTP IVIVKQGHEP PTFTGWFLAW DSNKWKN
//
